ArticleJournal for immunotherapy of cancer2022

Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types.

Jake G Maule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.